E7130

· Eisai Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E7130, covering 2025-03-06 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of E7130 in Participants With Solid Tumors [Phase 1]